Sitemap
Contact Us
Home
About Us
About Us Home
Senior Management
Board of Directors
Medical Advisory Board
Contact Us
Product Platforms
Platforms Home
GVAX® Cancer Immunotherapy
Oncolytic Virus Therapy
GVAX Pipeline
GVAX Pipeline Home
GVAX Prostate
GVAX Leukemia
GVAX Pancreatic
Investors
Investor Home
Press Releases
SEC Filings
Stock Chart and Quote
Fundamentals
Corporate Governance
Investor Kit
Scientific Presentations and Publications
Email Alerts
RSS Feeds
Calendar of Events
Careers
Careers Home
Benefits
GVAX Pipeline Home
GVAX Prostate
GVAX Leukemia
GVAX Pancreatic
GVAX® Cancer Immunotherapies
Company-sponsored
Prostate Cancer
Phase 3 trials terminated.
Lung Cancer
none
Investigator-sponsored
Leukemia
No description
Pancreatic Cancer
No Description